CarePredict recently announced a $29M Series A-3 investment co-led by SV Health Investors’ Medtech Convergence Fund and Aspire Healthtech Partners. And CarePredict’s innovative technology autonomously identifies changes in daily activity and behaviors that precede health issues such as urinary tract infections, falls, malnutrition, and depression.
The ability to detect the early signs of health concerns allows preventive care and preserves the overall well-being of older adults. Peer-reviewed and published studies have shown that CarePredict reduces hospitalizations by 39%, falls by 69% and increases the length of stay in a lower care setting by 67%.
The funding round was co-led by SV Health Investors’ Medtech Convergence Fund and Aspire Healthtech Partners. Existing institutional investors Secocha Ventures and Las Olas Venture Capital participated, along with family offices and individual investors.
KEY QUOTES:
“CarePredict has demonstrated excellent traction in senior housing and is well positioned to expand into the aging in place segment with a proven record of prediction and early intervention to not only preserve the health of older adults but to meaningfully affect healthcare costs positively.”
— Greg Madden, Managing Partner, SV Health Investors
“I have done an exhaustive search of the wearable technologies that can provide meaningful resident movement and physiological data in our vertically-integrated, owned, and managed senior housing portfolio. CarePredict’s unique approach to data accumulation and analysis allows us to realize our goal of virtual integration and predictive interventions. Along with this investment, we have started installing CarePredict in our communities.”
— Philip Gisi, CEO of Edgewood Healthcare and Managing Director of Aspire Healthtech Partners
“I am very pleased that SV Health Investors and Aspire Healthtech Partners have joined us in our vision to reimagine care for older adults and I look forward to accelerating our impact across all care settings and payer models in senior care.”
— Satish Movva, CEO & Founder, CarePredict
